サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513910

商業用バイオテクノロジー分離システムの世界市場

Commercial Biotechnology Separation Systems

出版日
ページ情報
英文 273 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
商業用バイオテクノロジー分離システムの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

商業用バイオテクノロジー分離システムの世界市場は2030年までに310億米ドルに達する見込み

2023年に253億米ドルと推定される商業用バイオテクノロジー分離システムの世界市場は、2023年から2030年にかけてCAGR 2.9%で成長し、2030年には310億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである従来法は、CAGR 2.7％を記録し、分析期間終了までに190億米ドルに達すると予測されます。現代的方法」セグメントは、分析期間中にCAGR 3.3％の成長が見込まれます。

米国市場は69億米ドルと推定、中国はCAGR 4.8％で成長予測

米国の商業用バイオテクノロジー分離システム市場は2023年に69億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに60億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と2.4%と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界の商業用バイオテクノロジー分離システム市場- 主要動向と促進要因のまとめ

商業用バイオテクノロジー分離システムは生体分子やタンパク質の精製・分析に不可欠であり、医薬品、農業、エネルギーなどさまざまな分野で極めて重要な役割を果たしています。これらの高度なシステムは、分離技術の継続的な発展とバイオ医薬品に対する世界の需要の増加により不可欠なものとなっています。市場の成長は、FDAのような規制機関が定める厳格な適正製造基準（GMP）ガイドラインを遵守するために、洗練された分離方法に対するニーズが高まっていることに後押しされています。最近の動向としては、ソニー株式会社のSFA-Life Sciences Cloud Platformや東ソー・バイオサイエンスGmbHのOctave BIOマルチカラムクロマトグラフィーシステムなどのシステムの開発が挙げられます。これらの技術革新はバイオテクノロジー分離の効率を高め、進化する業界標準に対応し、急成長する生体分子とタンパク質市場を支えています。

バイオテクノロジー分離システムの採用と拡大は、いくつかの重要な要因によって推進され、バイオテクノロジー分野全体における関連性と有用性の増大を確実なものにしています。特に、慢性疾患の蔓延と個別化医療の推進がバイオ医薬品の需要を高めており、治療用生体分子の精製に効果的な分離システムが必要とされています。強化クロマトグラフィー、ろ過、遠心分離などの分離方法の技術的進歩により、複雑な生物学的混合物をより効率的に取り扱うことができるようになった。さらに、厳格な規制遵守がバイオテクノロジー製品の高純度・高品質を義務付け、高度な分離プロセスの必要性を高めています。特にBRIC諸国などの新興市場におけるバイオテクノロジー分野の拡大と研究開発への多額の投資は、高度な分離技術へのニーズをさらに刺激しています。

新しい生物製剤のイントロダクションや、従来のバイオ医薬品から食品、飲食品、化粧品、農業といった産業への分離システムの応用拡大といった新たな動向や推進力は、バイオテクノロジー分離システムの適用範囲の広がりを浮き彫りにしています。材料科学の進歩は分離プロセスの性能を高め、バイオテクノロジー生産に不可欠な純度レベルと収率を向上させる。IoT、AI、機械学習を含むデジタル技術の分離システムへの統合は、操作を合理化し、プロセスのリアルタイムモニタリングと最適化を可能にします。世界の健康危機も、治療薬やワクチンの製造における分離システムの重要な役割にスポットライトを当て、パンデミックへの備えと対応における分離システムの重要性を強調しています。最後に、資金調達とベンチャーキャピタル投資の増加により、最先端の分離技術の導入が可能になり、イノベーションが促進され、高度なシステムの取得が容易になり、市場の成長と進化がさらに促進されています。

調査対象企業の例（注目の46社）

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-7990

Global Commercial Biotechnology Separation Systems Market to Reach US$31.0 Billion by 2030

The global market for Commercial Biotechnology Separation Systems estimated at US$25.3 Billion in the year 2023, is expected to reach US$31.0 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$19.0 Billion by the end of the analysis period. Growth in the Modern Method segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Commercial Biotechnology Separation Systems Market - Key Trends and Drivers Summarized

Commercial biotechnology separation systems are essential for the purification and analysis of biomolecules and proteins, playing a pivotal role in various sectors including pharmaceuticals, agriculture, and energy. These advanced systems have become integral due to continuous developments in separation technologies and a global increase in demand for biopharmaceutical products. The market's growth is buoyed by the rising need for sophisticated separation methods to adhere to stringent Good Manufacturing Practices (GMP) guidelines set by regulatory bodies like the FDA. Recent advancements include the development of systems such as the SFA - Life Sciences Cloud Platform by Sony Corporation and the Octave BIO multi-column chromatography system by Tosoh Bioscience GmbH. These innovations enhance the efficiency of biotechnological separations, catering to evolving industry standards, and support the burgeoning market for biomolecules and proteins.

The adoption and expansion of biotechnology separation systems are driven by several critical factors, ensuring their increasing relevance and utility across the biotechnology field. Notably, the growing prevalence of chronic diseases and the push towards personalized medicine have escalated the demand for biopharmaceuticals, necessitating effective separation systems for therapeutic biomolecule purification. Technological advancements in separation methods, such as enhanced chromatography, filtration, and centrifugation, allow for more efficient handling of complex biological mixtures. Additionally, strict regulatory compliance mandates high purity and quality in biotechnological products, bolstering the need for advanced separation processes. The expansion of the biotechnology sector, especially in emerging markets like the BRIC countries, coupled with significant investments in research and development, further stimulates the need for sophisticated separation technologies.

Emerging trends and drivers such as the introduction of new biologics and the expansion of separation system applications beyond traditional biopharmaceuticals into industries like food, beverage, cosmetics, and agriculture, highlight the broadening scope of biotechnology separation systems. Advances in material science enhance the performance of separation processes, increasing purity levels and yields crucial for biotechnological production. The integration of digital technologies, including IoT, AI, and machine learning, into separation systems streamlines operations, enabling real-time monitoring and optimization of processes. Global health crises have also spotlighted the vital role of separation systems in manufacturing therapeutics and vaccines, emphasizing their importance in pandemic preparedness and response. Lastly, increased funding and venture capital investments are enabling the adoption of cutting-edge separation technologies, fostering innovation and facilitating the acquisition of advanced systems, further driving the market's growth and evolution.

Select Competitors (Total 46 Featured) -

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Commercial Biotechnology Separation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Biopharmaceuticals Spurs Growth of Biotechnology Separation Systems
    • Advancements in Chromatography Techniques Propel Market Growth
    • Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity
    • Technological Innovations in Membrane Filtration Strengthen Business Case for Advanced Separation Systems
    • Government Regulations and Quality Standards Generate Demand for High-Precision Separation Technologies
    • Rising Adoption of Single-Use Technologies Drives Market Adoption
    • Emergence of Continuous Bioprocessing Throws the Spotlight on Efficient Separation Solutions
    • Growing Use of Monoclonal Antibodies Accelerates Demand for Advanced Separation Techniques
    • Increasing Investment in Biotech R&D Sustain Market Growth
    • Adoption of Automation and Robotics in Bioprocessing Fuels Demand for Integrated Separation Systems
    • Expansion of Biosimilars Market Propels Growth of Biotechnology Separation Systems
    • Growing Applications in Cell and Gene Therapy Expand Market Opportunities
    • Impact of Digital Transformation on Process Optimization
    • Increasing Focus on Process Analytical Technology (PAT) Drives Demand for Real-Time Separation Monitoring
    • Challenges in Scale-Up and Commercial Manufacturing Create Opportunities for Modular Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Commercial Biotechnology Separation Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Food & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION